These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36257993)

  • 1. Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges.
    Falabella M; Minczuk M; Hanna MG; Viscomi C; Pitceathly RDS
    Nat Rev Neurol; 2022 Nov; 18(11):689-698. PubMed ID: 36257993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic.
    Rasool N; Lessell S; Cestari DM
    Semin Ophthalmol; 2016; 31(1-2):107-16. PubMed ID: 26959136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial.
    Cwerman-Thibault H; Augustin S; Ellouze S; Sahel JA; Corral-Debrinski M
    C R Biol; 2014 Mar; 337(3):193-206. PubMed ID: 24702846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of leber hereditary optic neuropathy--prototype of an inherited optic neuropathy with mitochondrial dysfunction.
    Eichhorn-Mulligan K; Cestari DM
    Semin Ophthalmol; 2008; 23(1):27-37. PubMed ID: 18214789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mitochondrial diseases].
    Radelfahr F; Klopstock T
    Nervenarzt; 2019 Feb; 90(2):121-130. PubMed ID: 30643957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions.
    Mustafa MF; Fakurazi S; Abdullah MA; Maniam S
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32059522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial disorders: aetiologies, models systems, and candidate therapies.
    Farrar GJ; Chadderton N; Kenna PF; Millington-Ward S
    Trends Genet; 2013 Aug; 29(8):488-97. PubMed ID: 23756086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy.
    Shamsnajafabadi H; MacLaren RE; Cehajic-Kapetanovic J
    Cells; 2023 Aug; 12(15):. PubMed ID: 37566092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for mitochondrial disorders.
    Keshavan N; Minczuk M; Viscomi C; Rahman S
    J Inherit Metab Dis; 2024 Jan; 47(1):145-175. PubMed ID: 38171948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies for Leber hereditary optic neuropathy.
    Jurkute N; Harvey J; Yu-Wai-Man P
    Curr Opin Neurol; 2019 Feb; 32(1):99-104. PubMed ID: 30516647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing mtDNA levels as therapy for mitochondrial optic neuropathies.
    Ruiz-Pesini E; Emperador S; López-Gallardo E; Hernández-Ainsa C; Montoya J
    Drug Discov Today; 2018 Mar; 23(3):493-498. PubMed ID: 29337205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management.
    Newman NJ; Yu-Wai-Man P; Biousse V; Carelli V
    Lancet Neurol; 2023 Feb; 22(2):172-188. PubMed ID: 36155660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical research progress of gene therapy for Leber hereditary optic neuropathy].
    Wu YJ; Li WS
    Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):636-640. PubMed ID: 30107658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leber Hereditary Optic Neuropathy: A Mitochondrial Disease Unique in Many Ways.
    Bi R; Logan I; Yao YG
    Handb Exp Pharmacol; 2017; 240():309-336. PubMed ID: 27787713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilocus Mitochondrial Mutations Do Not Directly Affect the Efficacy of Gene Therapy for Leber Hereditary Optic Neuropathy.
    Yang S; Chen C; Yuan JJ; Wang SS; Wan X; He H; Ma SQ; Li B
    J Neuroophthalmol; 2020 Mar; 40(1):22-29. PubMed ID: 31246675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.
    Koilkonda RD; Yu H; Chou TH; Feuer WJ; Ruggeri M; Porciatti V; Tse D; Hauswirth WW; Chiodo V; Boye SL; Lewin AS; Neuringer M; Renner L; Guy J
    JAMA Ophthalmol; 2014 Apr; 132(4):409-20. PubMed ID: 24457989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
    Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
    Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leber hereditary optic neuropathy-new insights and old challenges.
    Sundaramurthy S; SelvaKumar A; Ching J; Dharani V; Sarangapani S; Yu-Wai-Man P
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2461-2472. PubMed ID: 33185731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy.
    Zhang Y; Tian Z; Yuan J; Liu C; Liu HL; Ma SQ; Li B
    Curr Gene Ther; 2017; 17(4):320-326. PubMed ID: 29189152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there treatment for Leber hereditary optic neuropathy?
    Peragallo JH; Newman NJ
    Curr Opin Ophthalmol; 2015 Nov; 26(6):450-7. PubMed ID: 26448041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.